Literature DB >> 7729327

Nitrate tolerance in angina therapy. How to avoid it.

J D Rutherford1.   

Abstract

Tolerance is the attenuation, or loss, of one or several of the effects of organic nitrates after long term administration. All organic nitrate regimens using frequent doses of long-acting nitrates (3 or more times daily), continuous delivery systems [transdermal nitroglycerin (glyceryl trinitrate) patches or continuous intravenous infusions of nitroglycerin] or long-acting (sustained release) preparations will result in partial or complete nitrate tolerance. There are several proposed mechanisms which may contribute to the development of tolerance including activation of neurohormonal mechanisms, plasma volume expansion and depletion of intracellular sulfhydryl cofactors. To avoid tolerance to long term nitrate therapy, regimens should be tailored to provide a 10- to 12-hour nitrate-free interval when possible. This means that antianginal prophylaxis can only be provided by nitrate therapy for some portion of each day, and that some patients will develop an increase in angina in the nitrate-free intervals which will necessitate short term therapy with sublingual nitroglycerin or a similar preparation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729327     DOI: 10.2165/00003495-199549020-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  21 in total

1.  Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.

Authors:  J D Parker; B Farrell; T Fenton; M Cohanim; J O Parker
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

2.  Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.

Authors:  J Dupuis; G Lalonde; R Lemieux; J L Rouleau
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

3.  Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

Authors:  J E Gage; O M Hess; T Murakami; M Ritter; J Grimm; H P Krayenbuehl
Journal:  Circulation       Date:  1986-05       Impact factor: 29.690

4.  The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.

Authors:  M M Bassan
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

Review 5.  Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention.

Authors:  U Elkayam
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

6.  A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction.

Authors:  Y Lis; D Bennett; G Lambert; D Robson
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

Review 7.  Antiplatelet and antithrombotic effects of organic nitrates.

Authors:  J Loscalzo
Journal:  Am J Cardiol       Date:  1992-09-24       Impact factor: 2.778

8.  Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine.

Authors:  H L Fung; S Chong; E Kowaluk; K Hough; M Kakemi
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

9.  Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.

Authors:  D H Schaer; L A Buff; R J Katz
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

10.  Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.

Authors:  J D Horowitz; C A Henry; M L Syrjanen; W J Louis; R D Fish; T W Smith; E M Antman
Journal:  Circulation       Date:  1988-04       Impact factor: 29.690

View more
  2 in total

Review 1.  Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.

Authors:  N S Gunasekara; S Noble
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

2.  Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents.

Authors:  Jimmy T Efird; Charulata Jindal; Andy C Kiser; Shahab A Akhter; Patricia B Crane; Alan P Kypson; Aaron L Sverdlov; Stephen W Davies; Linda C Kindell; Ethan J Anderson
Journal:  J Int Med Res       Date:  2018-05-29       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.